Literature DB >> 19178528

Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.

Rieko Tadokoro1, Trevor Bunch, John W R Schwabe, Ieuan A Hughes, Jane C Murphy.   

Abstract

OBJECTIVE: Androgen insensitivity syndrome (AIS) is associated with mutations throughout the androgen receptor (AR) gene. Different mutations at the same codon have been identified in individuals with various phenotypes suggesting the nature of the codon substituted may influence the degree of AIS. We investigated if phenotype could be predicted by comparing the functionality of AR mutations with those at the same codon of known phenotype. PATIENTS: We identified patients from the Cambridge Disorders of Sex Development Database with the AR substitutions: Phe754Ser with microphallus without hypospadias and Asp690Val with complete AIS. Mutations Phe754Leu, Phe754Val and Asp690deletion (Asp690del) have previously been reported to be associated with different degrees of AIS.
DESIGN: We characterized the functional properties of Phe754Ser, Phe754Leu, Phe754Val, Asp690Val and Asp690del receptor mutants in vitro and used the crystal structure of the AR ligand binding domain to model the mutations.
RESULTS: The receptor mutants Phe754Ser, Phe754Leu and Phe754Val bound androgen with decreasing affinity, while Asp690Val showed reduced affinity compared to Asp690del. A similar pattern of reduced activation was seen on androgen responsive elements. We suggest how the mutations could affect AR structure, resulting in the observed phenotypes.
CONCLUSIONS: The relative functional properties of Phe754 and Asp690 mutant AR receptors correlate broadly with their specific phenotypes. Therefore, comparing the molecular consequences of novel mutations with others at the same codon may be a useful aid to AIS patient management, particularly for sex of rearing decisions when prediction of functionality is important.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19178528     DOI: 10.1111/j.1365-2265.2008.03462.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.

Authors:  Christine Helsen; Vanessa Dubois; Annelien Verfaillie; Jacques Young; Mieke Trekels; Renée Vancraenenbroeck; Marc De Maeyer; Frank Claessens
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  The transcription intermediary factor 1β coactivates the androgen receptor.

Authors:  N Van Tilborgh; L Spans; C Helsen; L Clinckemalie; V Dubois; E Lerut; S Boonen; D Vanderschueren; F Claessens
Journal:  J Endocrinol Invest       Date:  2013-04-08       Impact factor: 4.256

3.  Novel Mutations Segregating with Complete Androgen Insensitivity Syndrome and their Molecular Characteristics.

Authors:  Agnieszka Malcher; Piotr Jedrzejczak; Tomasz Stokowy; Soroosh Monem; Karolina Nowicka-Bauer; Agnieszka Zimna; Adam Czyzyk; Marzena Maciejewska-Jeske; Blazej Meczekalski; Katarzyna Bednarek-Rajewska; Aldona Wozniak; Natalia Rozwadowska; Maciej Kurpisz
Journal:  Int J Mol Sci       Date:  2019-10-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.